R&G Pharma

301333
51.591.40% ( -0.73 )
Delay Closed: Nov 17, 15:00:00

Valuation

Current ValuationThe current P/E ratio is 42.76, within the reasonable range, cheaper than 25.22% of the time in the past 3 years, and the industry ranks 5/27, the industry Median 46.47.

42.76xP/E
Stock price¥51.59Earnings per share¥1.21

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 46.47x
012243648

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 46.47x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
300759SZPharmaron
42.45x15.50%¥75.14B
688758SHSepax Technologies
46.47x--¥9.21B
688315SHNovogene
48.11x13.01%¥7.23B
301333SZR&G Pharma
42.76x20.98%¥4.98B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.